Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0147401002
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Cancelled Post Market | 02245890 | ABBVIE CORPORATION | SYNAGIS | Human | Yes | Prescription | 1 | PALIVIZUMAB | 100 MG / VIAL |
Cancelled Post Market | 02245890 | ABBVIE CORPORATION | SYNAGIS | Human | Yes | Schedule D | 1 | PALIVIZUMAB | 100 MG / VIAL |
Marketed | 02438364 | ASTRAZENECA CANADA INC | SYNAGIS | Human | Yes | Prescription | 1 | PALIVIZUMAB | 100 MG / ML |
Marketed | 02438364 | ASTRAZENECA CANADA INC | SYNAGIS | Human | Yes | Schedule D | 1 | PALIVIZUMAB | 100 MG / ML |
Marketed | 02438372 | ASTRAZENECA CANADA INC | SYNAGIS | Human | Yes | Schedule D | 1 | PALIVIZUMAB | 50 MG / 0.5 ML |
Marketed | 02438372 | ASTRAZENECA CANADA INC | SYNAGIS | Human | Yes | Prescription | 1 | PALIVIZUMAB | 50 MG / 0.5 ML |
Application information
Related information
Contact us
Version 4.0.3